Prolight announces positive accounting adjustments for the full year 2023
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Prolight Diagnostics, developer of the digital point-of-care platform Psyros™, announced today that the company's 2023 year-end release contains an understated claim on the UK tax authority related to research and development. The revised estimate of Prolight's claim is approximately SEK 5.6 million higher than previously reported. In the annual report for 2023, which will be published on 23 April 2024, Prolight will therefore report a number of central items at higher estimated amounts than before.
Prolight's British subsidiary Psyros Diagnostics has reported an understated estimate of the company's tax claim for 2023 that falls short of the higher estimated amount by approximately SEK 5,639,000. The mistake was discovered during the work to complete Prolight's annual report for 2023.
“It is unfortunate that this was not discovered earlier so that our year-end report would have been more accurate. However, we are pleased that the revised estimate improves the results for 2023,” said Prolight’s CEO Ulf Bladin
Prolight's annual report will be published on 23 April 2024. The following summary of the group's income statement and balance sheet as of 31/12 2023 shows how the correction affects the group's key figures.
Income statement, Group
| Amount in SEK | Before adjustment | Group 1/1/23 12/31/23 | |
| Operating income etc | |||
| Net sales | 0 | ||
| Activated work for own account | 12 574 638 | ||
| Other income | 6 108 914 | 11 748 113 | |
| Total operating income | 18 683 552 | 24 322 751 | |
| Operating expense | |||
| Other external costs | -30 738 665 | ||
| Personnel costs | -15 204 74 | ||
| Depreciations | -775 245 | ||
| Other operating expenses | -122 84 | ||
| Total expenses | -46 841 495 | ||
| Operating loss | - 28 107 514 | -22 518 744 | |
| Result from financial investments | |||
| Other interest income and similar items | 546 346 | ||
| Other interests expenses and similar items | -189 009 | ||
| Total result from financial investments | 357 337 | ||
| Loss after financial items | - 27 750 177 | -22 161 407 | |
| Taxes | 0 | ||
| Loss for the year | - 27 750 177 | -22 161 407 | |
Balance Sheet, Group
| Amount in SEK | Group 12/31/23 | ||
| ASSETS | |||
| Fixed assets | |||
| Intangible assets | |||
| Capitalized expenditure | 137 999 970 | ||
| Patent | 1 864 686 | ||
| Acquired intangible assets | 85 922 459 | ||
| 225 787 115 | |||
| Tangible assets | |||
| Equipment, tools, fixtures and fittings | 2 694 278 | ||
| 2 694 278 | |||
| Total fixed assets | 228 481 393 | ||
| Current assets | |||
| Current receivables | |||
| Other receivables | 3 936 437 | 9 422 19 | |
| Prepaid expenses and accrued income | 158 025 | ||
| Subscribed capital unpaid | 31 197 429 | ||
| 35 291 891 | 40 777 65 | ||
| Cash and cash equivalents | 13 274 287 | ||
| Total current assets | 48 566 178 | 54 051 937 | |
| TOTAL ASSETS | 277 126 605 | 282 533 330 | |
| Amount in SEK | Group 12/31/23 | ||
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 34 682 296 | ||
| New share issue in progress | 15 038 855 | ||
| Other paid in capital | 237 226 294 | ||
| Other equity | - 46 175 770 | -40 655 053 | |
| Total equity | 240 885 667 | 246 292 392 | |
| Provisions | |||
| Accrued tax liabilities | 17 791 558 | ||
| Accrued tax liabilities | 17 791 558 | ||
| Current liabilities | |||
| Accounts payables | 4 175 528 | ||
| Other liabilities | 13 316 896 | ||
| Accrued expenses and deferred income | 956 956 | ||
| Total current liabilities | 18 449 380 | ||
| TOTAL EQUITY AND LIABILITIES | 277 126 605 | 282 533 330 | |